
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79283 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3’-Hydroxy Repaglinide (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications A metabolite of Repaglinide (R144500).<br>References Jarvis, B., et al.: Drugs, 59, 891 (2000), Niemi, M., et al.: Clin. Pharmacol. Ther., 70, 58 (2001), Hatorp, V., et al.: Clin. Pharmacokinet., 41, 471 (2002), Walsky, R., et al.: Drug Metab. Dispos., 33, 413 (2005),<br></p>Formula:C27H36N2O5Color and Shape:NeatMolecular weight:468.59Probenecid
CAS:Controlled Product<p>Applications Uricosuric.<br>References McKinney, S.E., et al.: J. Pharmacol. Exp. Ther., 102, 208 (1951), Israili, Z.H., et al.: J. Med. Chem., 15, 709 (1972), Al-Badr, A.A., et al.: Anal. Profiles Drug Subs., 10, 639 (1981), Cunningham, R.F., et al.: Clin. Pharmacokinet., 6, 135 (1981),<br></p>Formula:C13H19NO4SColor and Shape:WhiteMolecular weight:285.36Diclofenac Dodecyl Ester
<p>Applications Diclofenac Dodecyl Ester is a Diclofenac impurity. Diclofenac is a nonsteroidal inflammatory compound and cyclooxygenase (COX) inhibitor.<br>References Kretz-Rommel, A., et al.: Toxicol. Appl. Pharmacol., 120, 155 (1993), Petronilli, V., et al.: J. Biol. Chem., 269, 16638 (1994), Bort, R., et al.: J. Pharmacol. Exp. Ther., 288, 65 (1998), Poon, G., et al.: Drug Metab. Dispos., 29, 1608 (2001),<br></p>Formula:C26H35Cl2NO2Color and Shape:NeatMolecular weight:464.473-(butylamino)-5-(N-(3-carboxypropanoyl)sulfamoyl)-4-phenoxybenzoic acid
Formula:C21H24N2O8SMolecular weight:464.494-amino-N-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)benzenesulfonamide
CAS:Formula:C10H10N4O4SMolecular weight:282.27Bis-[Des(5-Chloro-2-carboxythienyl)] Rivaroxaban Phthalamide
CAS:Controlled ProductFormula:C36H36N6O10Color and Shape:NeatMolecular weight:712.713-(Formylamino)-1H-pyrazole-4-carboxamide
CAS:Controlled Product<p>Impurity Allopurinol EP Impurity B / Allopurinol USP Related Compound B<br>Stability Hygroscopic<br>Applications 3-(Formylamino)-1H-pyrazole-4-carboxamide (Allopurinol EP Impurity B) is an impurity of Allopurinol (A547300) with inhibitory effects on human hypoxanthine phosphoribosyltransferase.<br>References Krenitzky, T.A. et al.: J. Biol. Chem., 244, 1263 (1969);<br></p>Formula:C5H6N4O2Color and Shape:White To Off-WhiteMolecular weight:154.127Amiodarone EP Impurity C (Hydrochloride salt)
CAS:Formula:C25H30INO3HClMolecular weight:519.42 : 36.46

